Online inquiry

IVTScrip™ mRNA-Human ANKRD49, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21529MR)

This product GTTS-WK21529MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD49 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_017704.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 54851
UniProt ID Q8WVL7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD49, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21529MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK11909MR IVTScrip™ mRNA-Human ADAMTSL3, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADAMTSL3
GTTS-WK27465MR IVTScrip™ mRNA-Human ARPC1A, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARPC1A
GTTS-WK26933MR IVTScrip™ mRNA-Human ASXL3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASXL3
GTTS-WK13663MR IVTScrip™ mRNA-Human ACTL6A, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ACTL6A
GTTS-WK26795MR IVTScrip™ mRNA-Human ARHGAP30, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP30
GTTS-WK27177MR IVTScrip™ mRNA-Human ARRDC1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARRDC1
GTTS-WK17924MR IVTScrip™ mRNA-Human ANKRD39, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD39
GTTS-WK19761MR IVTScrip™ mRNA-Human ANXA3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANXA3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →